SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 7.76 |
| Enterprise Value ($M) | 1.95 |
| Book Value ($M) | -2.02 |
| Book Value / Share | -0.09 |
| Price / Book | -3.84 |
| NCAV ($M) | -2.22 |
| NCAV / Share | -0.10 |
| Price / NCAV | -3.50 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | n/a |
| Return on Assets (ROA) | -2.30 |
| Return on Equity (ROE) | -3.65 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.56 |
| Current Ratio | 2.56 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 7.09 |
| Assets | 7.29 |
| Liabilities | 9.31 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -15.66 |
| Net Income | -16.75 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -13.34 |
| Cash from Investing | -0.02 |
| Cash from Financing | 16.40 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D | Thomas Joseph Tracy | 5.00 | ||
| 13G | Anson Funds Management LP | 9.90 | ||
| 13G | Sabby Management, Llc | 9.90 | ||
| 13G/A | 3i, LP | 0.00 | -100.00 | |
| 13D | Fitzgerald Thomas A | 5.50 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 415,415 | 927,650 | 44.78 | |
| 846,289 | 2,610,218 | 32.42 | |
| 498,803 | 1,344,098 | 37.11 | |
| 713,779 | 1,992,358 | 35.83 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| RGC – Regencell Bioscience Holdings Limited | RGLS – Regulus Therapeutics Inc. |
| RMTI – Rockwell Medical, Inc. | RNTX – Rein Therapeutics Inc. |
| RNXT – RenovoRx, Inc. |
Financial data and stock pages provided by
Fintel.io